Downs, Bradley M.
Ding, Wanjun
Cope, Leslie M.
Umbricht, Christopher B.
Li, Wenge
He, Huihua
Ke, Xiaokang
Holdhoff, Matthias
Bettegowda, Chetan
Tao, Weiping
Sukumar, Saraswati http://orcid.org/0000-0002-5656-6703
Funding for this research was provided by:
U.S. Department of Defense (W81XWH1810482, W81XWH-18-1-0018)
National Institutes of Health (1R37CA230400, 1U01CA230691)
Article History
Received: 17 March 2021
Accepted: 22 April 2021
First Online: 5 May 2021
Declarations
:
: The Wuhan Clinical Sample Set was collected at the Renmin Hospital of Wuhan University, China, with Institutional Review Board IRB approval. Plasma was collected from newly diagnosed PCNSL at Johns Hopkins Hospital with IRB approval. Informed consent was obtained from all the subjects in this study for use of their samples for research. The healthy plasma samples and the pooled plasma sample were purchased from BioIVT (K<sub>2</sub>EDTA plasma, BioIVT, Hicksville, NY).
: Not applicable.
: S.S. has received research grants, licensing/royalty fees and consulting fees from Cepheid for the QM-MSP assays. No other authors have disclosed any conflicts of interest.